During the past decade, Specjalistyczna przychodnia lekarska POLIMED conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specjalistyczna przychodnia lekarska POLIMED" are "Metastatic Castrate Sensitive Prostate Cancer" (1 trials) and "Metastatic Prostate Cancer" (1 trials). Many other conditions were trialed in "Specjalistyczna przychodnia lekarska POLIMED" in a lesser frequency.

Most popular intervention types in "Specjalistyczna przychodnia lekarska POLIMED" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate (AA)" (1 trials), "Niraparib" (1 trials), "Placebo for Niraparib" (1 trials), "Prednisone" (1 trials) and "Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specjalistyczna przychodnia lekarska POLIMED" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Specjalistyczna przychodnia lekarska POLIMED". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Specjalistyczna przychodnia lekarska POLIMED, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specjalistyczna przychodnia lekarska POLIMED, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".